- Home
- NTHI vs CBAT Comparison
NTHI vs CBAT Comparison
Compare NTHI & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTHI | CBAT |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.0M | 93.1M |
| IPO Year | 2023 | 2025 |
Fundamental Metrics
Financial Performance| Metric | NTHI | CBAT |
|---|---|---|
| Price | $2.77 | $0.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | 139.3K | ★ 553.6K |
| Earning Date | 11-13-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,990.00 | N/A |
| Revenue This Year | N/A | $80.72 |
| Revenue Next Year | N/A | $31.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.50 | $0.46 |
| 52 Week High | $12.00 | $1.55 |
Technical Indicators
Market Signals| Indicator | NTHI | CBAT |
|---|---|---|
| Relative Strength Index (RSI) | 43.05 | 40.69 |
| Support Level | $2.50 | $0.75 |
| Resistance Level | $3.70 | $1.07 |
| Average True Range (ATR) | 0.25 | 0.11 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 34.98 | 0.04 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Ltd is a high-tech enterprise in China engaged in the development, manufacturing, and sales of new-energy high-power lithium-ion and sodium-ion batteries, as well as the production of raw materials for high-power lithium batteries. The Company's products and solutions are used in electric vehicles, light electric vehicles, energy storage systems, and other high-power applications.